Genotech (XKRX:066830) Debt-to-Asset : 0.00 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Genotech Debt-to-Asset?

Genotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩0 Mil. Genotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩0 Mil. Genotech's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was ₩12,233 Mil. Genotech's debt to asset for the quarter that ended in Dec. 2023 was 0.00.

Genotech Debt-to-Asset Historical Data

The historical data trend for Genotech's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genotech Debt-to-Asset Chart

Genotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.48

0.19

0.12

0.05

Genotech Semi-Annual Data
	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Debt-to-Asset	Get a 7-Day Free Trial				0.48	0.19	0.12	0.05	-

Competitive Comparison of Genotech's Debt-to-Asset

For the Biotechnology subindustry, Genotech's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genotech's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genotech's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Genotech's Debt-to-Asset falls into.

Genotech Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Genotech's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	12233.383
	=	0.00

Genotech's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	12233.383
	=	0.00

Genotech (XKRX:066830) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Genotech Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Genotech's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Genotech (XKRX:066830) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genotech Corp (XKRX:066830) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

26-69, Gajeongbuk-ro, Yuseong-gu, Daejeon, KOR, 305-343

Website

http://www.genotech.net

Genotech Corp is engaged in manufacturing basic pharmaceutical substances and biological agents.

Genotech (XKRX:066830) Headlines

No Headlines